Absorbable Nasal Implant Devices Sales

Absorbable Nasal Implant Devices Sales Market Outlook

The global absorbable nasal implant devices market is poised for significant growth, estimated to reach approximately USD 1.2 billion by 2035, with a compound annual growth rate (CAGR) of around 7.5% during the forecast period of 2025 to 2035. This growth can be attributed to the increasing prevalence of nasal disorders, a rising number of surgical procedures such as rhinoplasty and sinus surgeries, and an escalating awareness of the benefits of absorbable implants over traditional materials. Furthermore, technological advancements in the development of biocompatible and biodegradable materials, alongside a growing demand for minimally invasive surgical options, are expected to bolster market expansion. The trend towards outpatient surgeries and the rise in healthcare spending are additional factors driving the market forward, leading to heightened adoption of these advanced medical devices.

Growth Factor of the Market

The absorbable nasal implant devices market is experiencing robust growth due to several key factors. Firstly, the increasing incidence of chronic sinusitis and other nasal disorders has led to a higher demand for effective therapeutic solutions, thus driving the adoption of absorbable nasal implants. Secondly, the growing preference among healthcare professionals for minimally invasive procedures enhances the attractiveness of these devices, allowing for quicker recovery times and reduced post-operative complications. Moreover, advancements in material science have resulted in the creation of innovative implant designs that enhance patient outcomes, further fueling market growth. The rising trend of outpatient surgeries has also contributed positively, as these implants are tailored for such settings. Additionally, increased investment in healthcare infrastructure, particularly in emerging economies, is expected to present further opportunities for market expansion.

Key Highlights of the Market

• The market is projected to grow at a CAGR of 7.5% from 2025 to 2035.
• Absorbable nasal stents are anticipated to hold the largest market share due to their widespread application in various surgeries.
• North America is expected to dominate the market, accounting for over 40% of the global revenue.
• Biodegradable polymers are projected to be the most used material type due to their excellent biocompatibility and safety.
• Online sales channels are anticipated to witness significant growth, driven by the rising trend of e-commerce in the healthcare sector.

By Product Type

Absorbable Nasal Stents:

Absorbable nasal stents are a vital segment of the absorbable nasal implant devices market, primarily used to maintain nasal patency following surgical procedures. These stents are typically made from biocompatible materials that gradually dissolve, eliminating the need for a second surgical procedure to remove them. Their design allows for optimal airflow and drainage, which is crucial in postoperative recovery. The increasing incidence of nasal surgeries, including those aimed at correcting structural abnormalities, is contributing to the rising demand for these devices. As healthcare providers increasingly recognize the benefits of stenting in enhancing recovery outcomes, the market for absorbable nasal stents is expected to grow significantly.

Absorbable Nasal Packing Material:

This product type plays a critical role in nasal surgeries, particularly for controlling bleeding and preventing adhesions. Absorbable nasal packing materials are designed to be safely absorbed by the body over time, reducing the risks associated with non-absorbable alternatives. The convenience of not requiring removal is a significant advantage that has led to their widespread adoption. Advances in packing materials, which have improved their efficacy and patient comfort, are likely to further boost their market demand. The trend toward more complex surgical procedures is also expected to increase the reliance on these innovative materials, resulting in a positive outlook for this segment.

Absorbable Nasal Splints:

Absorbable nasal splints are designed to provide structural support and maintain nasal cavity alignment following corrective surgeries. They are made from materials that dissolve over time, promoting healing without the complications associated with traditional splints that require removal. The increasing popularity of rhinoplasty and other corrective surgeries is driving the demand for these splints, as they offer both functional and aesthetic benefits. As surgeons continue to seek solutions that enhance recovery and minimize patient discomfort, the market for absorbable nasal splints is expected to flourish. Furthermore, ongoing research into new materials that enhance the performance of these splints is likely to expand their applications in the future.

Absorbable Nasal Septal Implants:

Absorbable nasal septal implants are specifically designed for use in septoplasty and other procedures aimed at correcting nasal septum deformities. These implants provide structural support while minimizing the risk of complications associated with non-absorbable options. Their ability to be absorbed by the body makes them a desirable choice for both surgeons and patients, as they eliminate the need for follow-up procedures for removal. As awareness of the benefits of septoplasty continues to grow, so too does the market for absorbable nasal septal implants. Additionally, ongoing innovations in implant design and materials will likely enhance their efficacy and broaden their applications.

Absorbable Nasal Dressings:

Absorbable nasal dressings serve an essential function in postoperative recovery, providing a sterile environment for the healing nasal cavity and aiding in the management of bleeding. These dressings are typically made from innovative materials that promote healing while being gradually absorbed by the body. The demand for such products is increasing, fueled by the rising number of nasal surgeries and a growing emphasis on minimizing postoperative complications. As healthcare providers seek effective solutions to improve patient outcomes and comfort, absorbable nasal dressings are likely to gain prominence in the market. Their effectiveness in promoting faster recovery times will continue to drive their adoption in surgical settings.

By Application

Nasal Surgery:

Nasal surgery encompasses a range of procedures aimed at correcting structural and functional issues within the nasal cavity. This application segment is one of the largest drivers of the absorbable nasal implant devices market, as these implants are commonly used to facilitate healing and maintain nasal patency post-surgery. With the increasing prevalence of conditions like chronic sinusitis and congenital nasal deformities, the demand for effective surgical solutions is on the rise. As healthcare professionals continue to adopt absorbable implants for their benefits, the market for nasal surgery applications is expected to see substantial growth, supported by a trend towards more advanced and minimally invasive surgical techniques.

Rhinoplasty:

Rhinoplasty, often referred to as a “nose job,” is primarily performed for cosmetic reasons, as well as to correct breathing difficulties. The use of absorbable nasal implants in rhinoplasty procedures enhances recovery and minimizes discomfort, making them a preferred choice among surgeons and patients alike. The growing popularity of cosmetic surgery and the increasing number of people seeking aesthetic enhancements are propelling the demand for these devices in the rhinoplasty segment. Furthermore, the emphasis on achieving natural-looking results post-surgery has led to innovations in implant design, further driving the growth of this market segment. As societal acceptance of cosmetic procedures continues to increase, the rhinoplasty application is likely to experience significant growth in the coming years.

Sinus Surgery:

Sinus surgery is performed to alleviate conditions such as chronic sinusitis and nasal polyps, and the use of absorbable nasal implants is becoming increasingly common in this area. These implants help maintain sinus drainage and facilitate healing after surgery, thus improving patient outcomes. The rising incidence of sinus-related conditions due to environmental factors and lifestyle changes is driving the demand for surgical interventions, leading to a corresponding increase in the usage of absorbable devices. The advantages of these implants, including their ability to reduce postoperative complications and enhance recovery times, are likely to continue to boost their application in sinus surgery. As surgical techniques evolve, the market for absorbable nasal implants in this segment is expected to expand further.

Others:

The "Others" application segment includes a variety of less common nasal procedures that also utilize absorbable nasal implants. This segment accounts for a smaller but significant share of the market, highlighting the versatility of these devices across different surgical applications. As healthcare practitioners continue to explore the use of absorbable implants in diverse nasal surgeries, the potential for growth in this segment is notable. The continuous development of new applications and techniques in nasal surgery will contribute to the expanding use of absorbable nasal implants in a wider array of procedures. Overall, the increasing acceptance of these devices in various surgical scenarios bodes well for the growth of the "Others" application segment.

By Distribution Channel

Hospitals & Clinics:

Hospitals and clinics represent the primary distribution channel for absorbable nasal implant devices, accounting for a significant share of the market. Surgeons working in these settings frequently opt for absorbable implants due to their proven efficacy in enhancing surgical outcomes and patient recovery. The availability of advanced surgical technologies within hospitals enables healthcare professionals to implement these devices effectively. Additionally, hospitals often have established partnerships with manufacturers of absorbable nasal implants, facilitating streamlined procurement and distribution processes. The growing number of surgical procedures performed in hospitals is expected to drive the demand for absorbable nasal implants in this channel, ensuring its dominance in the market.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining traction as viable distribution channels for absorbable nasal implant devices, driven by the trend toward outpatient procedures. These centers typically focus on providing minimally invasive surgeries, which aligns well with the benefits of absorbable implants. The growing preference for same-day discharge after surgeries has led to increased utilization of ASCs, contributing to the market growth in this channel. Additionally, as more healthcare providers recognize the advantages of performing nasal surgeries in an ASC setting, including lower costs and reduced patient stress, the demand for absorbable nasal implants is expected to rise. The ongoing expansion of ASCs and their focus on patient-centered care will further bolster this segment of the market.

Online Sales:

The online sales channel for absorbable nasal implant devices is emerging as a significant distribution pathway due to the growing trend of e-commerce in the healthcare sector. Patients and healthcare providers alike are increasingly turning to online platforms for purchasing medical supplies, including absorbable implants. This channel offers convenience, competitive pricing, and a wider selection of products, which appeals to both practitioners and patients. Furthermore, the COVID-19 pandemic has accelerated the shift toward online purchasing, as healthcare providers seek to minimize in-person interactions. As e-commerce continues to evolve and improve, the online sales channel for absorbable nasal implants is expected to grow, providing additional opportunities for market expansion.

By Material Type

Biodegradable Polymers:

Biodegradable polymers are the most widely used material type in the production of absorbable nasal implants, due to their favorable properties, such as biocompatibility and the ability to safely degrade within the body. These materials provide the necessary structural support during the healing process, gradually dissolving as tissue regeneration occurs. The continuous advancement in polymer technology has led to the development of new formulations that enhance the performance and safety of absorbable implants. As surgeons increasingly prefer biodegradable polymers for their proven effectiveness, the demand for this material type is expected to continue to grow. The rising focus on patient safety and outcomes will further bolster the use of biodegradable polymers in the absorbable nasal implant market.

Collagen:

Collagen is another key material used in absorbable nasal implants, particularly for its natural origin and compatibility with human tissues. Its utilization in medical devices is well-established, as collagen provides excellent support for healing, minimizes the risk of foreign body reactions, and promotes tissue integration. The trend toward using naturally derived materials in medical devices has driven the increased demand for collagen-based implants. As researchers and manufacturers develop more advanced collagen formulations, the market for absorbable nasal implants made from this material is expected to expand significantly. The emphasis on biocompatibility and the patient-centric approach in healthcare will further enhance the appeal of collagen-based implants in this segment.

Gelatin:

Gelatin, derived from collagen, is also widely employed in absorbable nasal implants due to its favorable properties, including biocompatibility and biodegradability. Gelatin-based implants offer a temporary scaffold for healing while being safely absorbed by the body. The advantages of utilizing gelatin in nasal implants lie in its ability to promote rapid healing and minimize scarring, which is particularly important in nasal surgeries. With the growing focus on patient outcomes and the increasing incidence of nasal procedures, the demand for gelatin-based absorbable implants is on the rise. As manufacturers continue to innovate and improve gelatin formulations, the market for this material type is expected to witness substantial growth in the coming years.

Others:

The "Others" category encompasses a variety of alternative materials used in absorbable nasal implants, broadening the market's scope. These materials may include synthetic compounds or composites designed to enhance the performance characteristics of nasal implants. The versatility and adaptability of various material types allow for more tailored solutions to meet specific surgical requirements. As the demand for personalized healthcare solutions grows, the "Others" category is expected to expand, driven by ongoing research and development efforts aimed at optimizing the properties of absorbable implants. This segment's growth reflects the dynamic nature of the market and the continuous evolution of materials science in the field of medical devices.

By Region

The regional analysis of the absorbable nasal implant devices market reveals distinct trends and dynamics that influence market growth. North America is anticipated to maintain its dominance, accounting for a significant share of the global market, driven by advanced healthcare infrastructure, high healthcare spending, and a favorable regulatory environment. The market in this region is projected to grow at a CAGR of approximately 8.0% during the forecast period, supported by the increasing prevalence of nasal surgeries and a growing emphasis on minimally invasive techniques. The presence of key players and ongoing technological innovations will further bolster the market's expansion in North America.

Europe is another prominent region in the absorbable nasal implant devices market, characterized by a high demand for advanced medical devices and a strong focus on research and development. The growing number of surgical procedures, coupled with increasing patient awareness about the benefits of absorbable implants, is expected to drive market growth in this region. Asia Pacific is also emerging as a significant market, fueled by rising healthcare expenditures, increasing disposable incomes, and a growing patient population. The region is projected to witness substantial growth in the coming years, with an estimated CAGR of around 7.0%. The ongoing development of healthcare infrastructure in Asia Pacific countries will further contribute to the market's expansion, presenting ample opportunities for growth in the absorbable nasal implant devices segment.

Opportunities

The absorbable nasal implant devices market is poised for numerous opportunities, particularly in emerging markets where healthcare infrastructure is rapidly developing. As countries in regions like Asia Pacific, Latin America, and the Middle East invest in healthcare improvements, the demand for advanced medical devices is expected to rise significantly. This trend presents an opportunity for manufacturers to expand their product offerings and establish a presence in these growing markets. Additionally, the increasing prevalence of nasal disorders and a higher number of surgical procedures will drive the demand for absorbable implants, creating a favorable environment for market players to capitalize on. By aligning their strategies with local healthcare needs, companies can effectively tap into these emerging opportunities and enhance their market reach.

Furthermore, ongoing research and development initiatives aimed at improving the efficacy and safety of absorbable nasal implants present significant growth potential for the market. Manufacturers that invest in innovative technology and materials will be well-positioned to introduce new and enhanced products to cater to the evolving needs of healthcare providers and patients. As the focus on personalized medicine and patient-centric approaches continues to rise, the development of tailored absorbable implant solutions can open new avenues for growth. Collaborations with healthcare professionals and academic institutions will also foster innovation, leading to the emergence of novel products that address specific surgical challenges and enhance patient outcomes.

Threats

Despite the promising growth outlook for the absorbable nasal implant devices market, several threats could impede its expansion. The primary threat comes from the presence of alternative treatment options and non-absorbable materials that may be preferred by some surgeons due to their established track record. These alternatives can pose competition to absorbable implants, influencing the choices made by healthcare providers. Additionally, the high costs associated with developing and manufacturing advanced absorbable implant devices may limit market entry for smaller players, thereby consolidating market power among a few large manufacturers. Furthermore, regulatory challenges related to product approval can pose significant hurdles, potentially delaying the introduction of innovative products and affecting market dynamics.

Additionally, the ongoing global pandemic has introduced uncertainties in healthcare delivery, potentially impacting elective surgical procedures where absorbable implants are utilized. The reluctance of patients to undergo surgery during public health crises may lead to reduced demand for absorbable nasal implants in the short term. Lastly, challenges associated with the supply chain, including material shortages and logistics disruptions, can pose risks to manufacturers' ability to meet market demand. As the industry navigates these threats, companies must remain agile and proactive in addressing potential challenges to sustain their growth trajectory.

Competitor Outlook

• Medtronic
• Smith & Nephew
• Johnson & Johnson
• Stryker Corporation
• Boston Scientific Corporation
• ConMed Corporation
• Integrity Implants
• Otonomy, Inc.
• Acclarent, Inc.
• Merit Medical Systems, Inc.
• Halyard Health, Inc.
• Medline Industries, Inc.
• Advanced Medical Technology, Inc.
• NuVasive, Inc.
• Sanofi S.A.

The competitive landscape of the absorbable nasal implant devices market is characterized by the presence of several established players and emerging companies striving to carve out a share of this growing sector. Leading manufacturers are focusing on product innovation and technological advancements to differentiate themselves in a crowded market. This includes the development of novel materials and designs that enhance the effectiveness and safety of absorbable implants, setting the stage for fierce competition among key players. Collaborations and partnerships with healthcare providers, as well as investments in research and development, are common strategies employed by these companies to strengthen their market positions and expand their product portfolios.

Some of the major companies, such as Medtronic and Johnson & Johnson, hold significant market shares in the absorbable nasal implant devices segment due to their extensive experience, strong brand recognition, and vast distribution networks. Medtronic, for instance, has been at the forefront of developing innovative healthcare solutions, including absorbable implants, leveraging its expertise in surgical technologies. Johnson & Johnson's diverse product offerings and focus on research allow it to address various medical needs, including those related to nasal surgery. These companies continually invest in advancing their technologies, ensuring they remain competitive in an ever-evolving market.

Similarly, companies like Boston Scientific and Stryker Corporation are actively engaged in expanding their offerings in the realm of absorbable nasal implants. Boston Scientific is known for its commitment to innovation, and its research initiatives have led to the development of advanced implant technologies. Stryker, on the other hand, has a strong presence in surgical instruments and implants, making it well-positioned to capture opportunities in the absorbable nasal device market. By focusing on enhancing patient outcomes and optimizing surgical procedures, these companies are poised to exert a significant influence on the market dynamics of absorbable nasal implant devices.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Sanofi S.A.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Otonomy, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 NuVasive, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Smith & Nephew
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Acclarent, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Johnson & Johnson
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 ConMed Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Integrity Implants
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Stryker Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Halyard Health, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Medline Industries, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Merit Medical Systems, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Advanced Medical Technology, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Absorbable Nasal Implant Devices Sales Market, By Application
    • 6.1.1 Nasal Surgery
    • 6.1.2 Rhinoplasty
    • 6.1.3 Sinus Surgery
    • 6.1.4 Others
  • 6.2 Absorbable Nasal Implant Devices Sales Market, By Product Type
    • 6.2.1 Absorbable Nasal Stents
    • 6.2.2 Absorbable Nasal Packing Material
    • 6.2.3 Absorbable Nasal Splints
    • 6.2.4 Absorbable Nasal Septal Implants
    • 6.2.5 Absorbable Nasal Dressings
  • 6.3 Absorbable Nasal Implant Devices Sales Market, By Material Type
    • 6.3.1 Biodegradable Polymers
    • 6.3.2 Collagen
    • 6.3.3 Gelatin
    • 6.3.4 Others
  • 6.4 Absorbable Nasal Implant Devices Sales Market, By Distribution Channel
    • 6.4.1 Hospitals & Clinics
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Online Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Absorbable Nasal Implant Devices Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Absorbable Nasal Implant Devices Sales market is categorized based on

By Product Type

• Absorbable Nasal Stents
• Absorbable Nasal Packing Material
• Absorbable Nasal Splints
• Absorbable Nasal Septal Implants
• Absorbable Nasal Dressings

By Application

• Nasal Surgery
• Rhinoplasty
• Sinus Surgery
• Others

By Distribution Channel

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Online Sales

By Material Type

• Biodegradable Polymers
• Collagen
• Gelatin
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Smith & Nephew
• Johnson & Johnson
• Stryker Corporation
• Boston Scientific Corporation
• ConMed Corporation
• Integrity Implants
• Otonomy, Inc.
• Acclarent, Inc.
• Merit Medical Systems, Inc.
• Halyard Health, Inc.
• Medline Industries, Inc.
• Advanced Medical Technology, Inc.
• NuVasive, Inc.
• Sanofi S.A.